20/20 OptimEyes Technologies

20/20 OptimEyes is redefining drug delivery with a mucoadhesive nanoparticle platform that keeps medicines where they’re needed most. Starting with once-weekly eye drops for glaucoma, our technology makes proven therapies more effective, longer lasting, and easier for patients — unlocking a new generation of treatments across ophthalmology and other mucosal diseases.